192 related articles for article (PubMed ID: 26342260)
21. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.
Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C
Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with
Zuccato C; Cosenza LC; Zurlo M; Lampronti I; Borgatti M; Scapoli C; Gambari R; Finotti A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948226
[TBL] [Abstract][Full Text] [Related]
23. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.
Basak A; Hancarova M; Ulirsch JC; Balci TB; Trkova M; Pelisek M; Vlckova M; Muzikova K; Cermak J; Trka J; Dyment DA; Orkin SH; Daly MJ; Sedlacek Z; Sankaran VG
J Clin Invest; 2015 Jun; 125(6):2363-8. PubMed ID: 25938782
[TBL] [Abstract][Full Text] [Related]
24. Sustained fetal hemoglobin induction in vivo is achieved by
Uchida N; Ferrara F; Drysdale CM; Yapundich M; Gamer J; Nassehi T; DiNicola J; Shibata Y; Wielgosz M; Kim YS; Bauler M; Throm RE; Haro-Mora JJ; Demirci S; Bonifacino AC; Krouse AE; Linde NS; Donahue RE; Ryu B; Tisdale JF
Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910976
[TBL] [Abstract][Full Text] [Related]
25. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
26. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
Xu J; Bauer DE; Kerenyi MA; Vo TD; Hou S; Hsu YJ; Yao H; Trowbridge JJ; Mandel G; Orkin SH
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6518-23. PubMed ID: 23576758
[TBL] [Abstract][Full Text] [Related]
27. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment.
Funnell AP; Prontera P; Ottaviani V; Piccione M; Giambona A; Maggio A; Ciaffoni F; Stehling-Sun S; Marra M; Masiello F; Varricchio L; Stamatoyannopoulos JA; Migliaccio AR; Papayannopoulou T
Blood; 2015 Jul; 126(1):89-93. PubMed ID: 26019277
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
[TBL] [Abstract][Full Text] [Related]
29. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Ali H; Khan F; Musharraf SG
Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin.
Lampronti I; Bianchi N; Borgatti M; Fibach E; Prus E; Gambari R
Eur J Haematol; 2003 Sep; 71(3):189-95. PubMed ID: 12930320
[TBL] [Abstract][Full Text] [Related]
31. Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation.
Iftikhar F; Khan MBN; Musharraf SG
Eur J Pharmacol; 2021 Jan; 891():173700. PubMed ID: 33137331
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
[TBL] [Abstract][Full Text] [Related]
33. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
34. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
36. Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.
Bianchi N; Finotti A; Ferracin M; Lampronti I; Zuccato C; Breveglieri G; Brognara E; Fabbri E; Borgatti M; Negrini M; Gambari R
PLoS One; 2015; 10(4):e0121567. PubMed ID: 25849663
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters.
Breveglieri G; Salvatori F; Finotti A; Cosenza LC; Zuccato C; Bianchi N; Breda L; Rivella S; Bresciani A; Bisbocci M; Borgatti M; Gambari R
Anal Bioanal Chem; 2019 Nov; 411(29):7669-7680. PubMed ID: 31273412
[TBL] [Abstract][Full Text] [Related]
38. Post-Transcriptional Genetic Silencing of
Esrick EB; Lehmann LE; Biffi A; Achebe M; Brendel C; Ciuculescu MF; Daley H; MacKinnon B; Morris E; Federico A; Abriss D; Boardman K; Khelladi R; Shaw K; Negre H; Negre O; Nikiforow S; Ritz J; Pai SY; London WB; Dansereau C; Heeney MM; Armant M; Manis JP; Williams DA
N Engl J Med; 2021 Jan; 384(3):205-215. PubMed ID: 33283990
[TBL] [Abstract][Full Text] [Related]
39. Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.
Ghedira ES; Lecerf L; Faubert E; Costes B; Moradkhani K; Bachir D; Galactéros F; Pissard S
Haematologica; 2013 Feb; 98(2):305-8. PubMed ID: 22801970
[TBL] [Abstract][Full Text] [Related]
40. BCL11A represses HBG transcription in K562 cells.
Chen Z; Luo HY; Steinberg MH; Chui DH
Blood Cells Mol Dis; 2009; 42(2):144-9. PubMed ID: 19153051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
